BioMotiv creates pharmaceutical spinoff

Story excerpt provided by Crain’s Cleveland Business.

Written by Chuck Soder.

BioMotiv of Beachwood has formed a new pharmaceutical company that aims to commercialize a technology that could be used to treat inflammatory and vascular disorders.

The spinoff, Sujana Biotech LLC, licensed the technology from Case Western Reserve University. It also recently raised $800,000 from four investors, according to a document the company filed with the U.S. Securities and Exchange Commission.

Click here to read the complete article.

Originally published July 1, 2015.